World Bank bars Famy Care, Olive Healthcare from receiving its contractsPost published:August 5, 2017Post category:Industry NewsA World Bank investigation has found that pharma firms Famy Care and Olive Healthcare engaged in ‘fraud’ and ‘misconduct’ Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDigital transactions gain momentum, shows RBI data Next PostONGC buys 80% participating interest in GSPC block You Might Also Like The Case for Computing at the Edge May 24, 2019 Drug regulators, industry body to conduct workshops on manufacturing norms September 15, 2017 AutomationDirect announces ProSense digital panel meters in 1/32 and 1/8 DIN sizes January 22, 2020